Bulletin
Investor Alert

Rigel Pharmaceuticals Inc.

NAS: RIGL

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 4:54 p.m.

/zigman2/quotes/207222917/composite

$

3.54

Change

+0.16 +4.73%

Volume

Volume 8,269

Quotes are delayed by 20 min

/zigman2/quotes/207222917/composite

Previous close

$ 3.45

$ 3.38

Change

-0.07 -2.03%

Day low

Day high

$3.37

$3.50

Open

52 week low

52 week high

$2.36

$5.50

Open

Annual Financials for Rigel Pharmaceuticals Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries (69.22M)(77.99M)(70.48M)(66.89M)(29.74M)
Depreciation, Depletion & Amortization 941,000465,000594,000683,000706,000
Depreciation and Depletion 941,000465,000594,000683,000706,000
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 8.18M5.4M6.94M8.04M7.18M
Funds from Operations (60.1M)(72.13M)(62.95M)(58.17M)(21.86M)
Extraordinaries -----
Changes in Working Capital (15.79M)(5.43M)4.12M23.38M(23.09M)
Receivables 203,000-(4.08M)(6.03M)(5.86M)
Accounts Payable 2.8M(2.95M)3.76M(2.24M)(331,000)
Other Assets/Liabilities (17.46M)(6.84M)386,00030.84M(20.53M)
Net Operating Cash Flow (75.89M)(77.56M)(58.83M)(34.79M)(44.96M)

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (804,000)(164,000)(1.11M)(1.46M)(1.26M)
Capital Expenditures (Fixed Assets) (804,000)(164,000)(1.11M)(1.46M)(1.26M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses 88,000732,000---
Purchase/Sale of Investments 25.6M(20.04M)26.07M(22.2M)48.73M
Purchase of Investments (103.05M)(116.86M)(78M)(145.33M)(81.71M)
Sale/Maturity of Investments 128.65M96.82M104.07M123.13M130.43M
Other Uses -----
Other Sources -----
Net Investing Cash Flow 24.88M(19.47M)24.96M(23.66M)47.47M

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 25.18M117.69M71.89M1.58M2.6M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 25.18M117.69M71.89M1.58M2.6M
Proceeds from Stock Options 23.59M114.18M67.16M--
Other Proceeds from Sale of Stock 1.6M3.51M4.73M1.58M2.6M
Issuance/Reduction of Debt, Net ---3.06M2.75M
Change in Current Debt ---(6.73M)(7.23M)
Change in Long-Term Debt ---9.79M9.98M
Issuance of Long-Term Debt ---9.79M9.98M
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 25.18M117.69M71.89M4.64M5.34M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (25.82M)20.66M38.03M(53.8M)7.85M
Free Cash Flow (76.69M)(77.72M)(59.93M)(36.24M)(46.22M)
Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.